Latest Drug Safety news
FDA Creates “Green List” of GLP-1 Drug Ingredients Approved for Entry in the U.S.
posted September 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Benefits of Long-Term Routine Lab Drug Toxicity Monitoring Unclear in RA
posted August 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Requiring Stronger Safety Labels for Opioid Medications
posted August 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Antiseizure Meds With Known or Uncertain Risks Continue to Be Prescribed in Pregnancy
posted July 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Unintentional Ingestion of Recreational Drugs Increased, Especially Since 2013 
Probable Postictal Psychosis Linked to Risk for Subsequent Primary Psychotic Disorders 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer Related Articles
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings 
Two HLA Class I Alleles Independently Linked to Allopurinol-Induced SCARs 
FDA Sends 100 Cease-and-Desist Letters in Crackdown on DTC Drug Advertisements 
Study Compares Benefits, Harms of Treatments for Chronic Hives Monthly Specialist Briefings
Stay Connected
